Scalper1 News
Shares of embattled specialty drugmaker Allergan (AGN) were up 2.5% in midday trading on the stock market today after Leerink upgraded the stock based on valuation. Analyst Seamus Fernandez lifted his rating to outperform from sector perform late Thursday, following the stock’s 12% decline over the previous six trading days. The drop seemed to have been touched off by the weak Q2 earnings report of Valeant Pharmaceuticals International (VRX), Scalper1 News
Scalper1 News